Increased drug concentration and repeated eye drop administration as strategies to optimize topical drug delivery: A fluorophotometric study in healthy dogs
Open Access
- 23 June 2023
- journal article
- research article
- Published by Wiley in Veterinary Ophthalmology
- Vol. 26 (4) , 331-338
Abstract
Objectives: Determine tear film kinetics with different fluorescein concentrations and repeated eye drop administration at various time intervals.Animals Studied: Six healthy Beagles.Procedures: Six experiments were conducted on separate days: single eye drop administration (control) or two separate eye drops administered at 30 s, 1, 2, 5, and 10 min intervals. For each experiment, one eye received 0.3% fluorescein solution while the other eye received 1% fluorescein solution, and tear fluid was collected with capillary tubes at 0, 1, 5, 10, 20, 30, 40, 50, 60, 90, 120, and 180 min. Fluorescein concentrations were measured using automated fluorophotometry.Results: Compared with 0.3% solution, eyes receiving 1% fluorescein solution had significantly higher tear film concentrations (p ≤ .046) and the area‐under‐the‐fluorescein‐time curve was twofold greater (p = .005). Compared with control: (i) Tear film concentrations were significantly higher for up to 20 min when repeating administration 30 s to 5 min after the first drop (p ≤ .006); (ii) The highest increase in area‐under‐the‐curve was obtained with 2 and 5 min intervals for 0.3% (+109%–130%) and 1% solutions (+153%–157%); (iii) The highest increase in median precorneal retention time (defined as tear film concentration < 5% from baseline values) was obtained with 5 min intervals for 0.3% (55 min vs. 15 min in control) and 2–5 min intervals for 1% solutions (50 min vs. 25 min in control).Conclusions: Drug delivery to the ocular surface can be enhanced by using more concentrated formulations and/or by repeating eye drop administration 2–5 min after the first dose.Keywords
This publication has 26 references indexed in Scilit:
- Pharmacokinetics and aqueous humor penetration of levofloxacin 1.5% and moxifloxacin 0.5% in patients undergoing cataract surgeryClinical Ophthalmology, 2016
- Ocular Penetration and Pharmacokinetics of Topical Clarithromycin Eye Drops to RabbitsJournal of Ocular Pharmacology and Therapeutics, 2013
- LONG-TERM POTENCY, STERILITY, AND STABILITY OF VANCOMYCIN, CEFTAZIDIME, AND MOXIFLOXACIN FOR TREATMENT OF BACTERIAL ENDOPHTHALMITISRetina, 2011
- Stability and antibacterial potency of ceftazidime and vancomycin eyedrops reconstituted in BSS® against Pseudomonas aeruginosa and Staphylococcus aureusActa Ophthalmologica, 2009
- Effect of Blinking on Tear Volume After Instillation of Midviscosity Artificial TearsAmerican Journal of Ophthalmology, 2008
- The ocular penetration of levofloxacin 1.5% and gatifloxacin 0.3% ophthalmic solutions in subjects undergoing corneal transplant surgeryCurrent Medical Research and Opinion, 2007
- Does the Dose Matter?Clinical Infectious Diseases, 2001
- Canine and Feline Primary Ocular Bacterial InfectionsVeterinary Clinics of North America: Small Animal Practice, 2000
- In vitro potency and stability of fortified ophthalmic antibioticsAustralian and New Zealand Journal of Ophthalmology, 1999
- An In Vitro Study of the Potency and Stability of Fortified Ophthalmic Antibiotic PreparationsAmerican Journal of Ophthalmology, 1991